Celltrion
068270.KS
#771
Rank
A$43.40 B
Marketcap
A$198.40
Share price
1.48%
Change (1 day)
5.18%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): A$2.88

According to Celltrion 's latest financial reports the company's current EPS (TTM) is A$2.76. an increase over its 2024 EPS that were of A$1.79.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025A$4.72163.66%
2024A$1.79-53.73%
2023A$3.87-2.08%
2022A$3.95-11.72%
2021A$4.482.03%
2020A$4.3982.8%
2019A$2.4018.31%
2018A$2.03-36.33%
2017A$3.19161.25%
2016A$1.222.86%
2015A$1.1917.84%
2014A$1.015.87%
2013A$0.95-70.85%
2012A$3.26134.09%
2011A$1.3943.59%
2010A$0.9774.49%
2009A$0.56317.8%
2008A$0.13-71.7%
2007A$0.47